reference/23661982

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/23661982

Outgoing Links

Predicate	Object
contentType	Comparative Study\|Journal Article
endingPage	75
issn	0041-008X
pageRange	65-75
publicationName	Toxicology and Applied Pharmacology
startingPage	65
bibliographicCitation	Abdel-Maged AE, Gad AM, Abdel-Aziz AK, Aboulwafa MM, Azab SS. Comparative study of anti-VEGF Ranibizumab and Interleukin-6 receptor antagonist Tocilizumab in Adjuvant-induced Arthritis. Toxicol Appl Pharmacol. 2018 Oct 01;356():65–75. doi: 10.1016/j.taap.2018.07.014. PMID: 30025850.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0003-1709-1183 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-0253-8280 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_fffbc6925877feb117349bf2db9a56f5 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_59e5b0f71983dd63ddd90ce7ea4f2d6a http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_46a42636469aadec21c4e581ec50f2d0 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_8725353e1949701143c2de1793ae5215
date	2018-10-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://pubmed.ncbi.nlm.nih.gov/30025850 https://doi.org/10.1016/j.taap.2018.07.014
isPartOf	http://rdf.ncbi.nlm.nih.gov/pubchem/journal/7769 https://portal.issn.org/resource/ISSN/0041-008X
language	English
source	https://pubmed.ncbi.nlm.nih.gov/ https://www.crossref.org/
title	Comparative study of anti-VEGF Ranibizumab and Interleukin-6 receptor antagonist Tocilizumab in Adjuvant-induced Arthritis
discusses	http://id.nlm.nih.gov/mesh/M0029619 http://id.nlm.nih.gov/mesh/M0027742 http://id.nlm.nih.gov/mesh/M0481787 http://id.nlm.nih.gov/mesh/M0328153 http://id.nlm.nih.gov/mesh/M0556300 http://id.nlm.nih.gov/mesh/M0488127 http://id.nlm.nih.gov/mesh/M0356369 http://id.nlm.nih.gov/mesh/M0013595
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D019947Q000037 http://id.nlm.nih.gov/mesh/D000069579Q000627 http://id.nlm.nih.gov/mesh/D020533Q000627 http://id.nlm.nih.gov/mesh/D042461Q000037 http://id.nlm.nih.gov/mesh/D018501Q000627 http://id.nlm.nih.gov/mesh/D061067Q000627 http://id.nlm.nih.gov/mesh/D001169Q000188
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D002356Q000473 http://id.nlm.nih.gov/mesh/D008099Q000201 http://id.nlm.nih.gov/mesh/D007249Q000473 http://id.nlm.nih.gov/mesh/D008297 http://id.nlm.nih.gov/mesh/D051381 http://id.nlm.nih.gov/mesh/D020533Q000494 http://id.nlm.nih.gov/mesh/D017209Q000187 http://id.nlm.nih.gov/mesh/D061067Q000494 http://id.nlm.nih.gov/mesh/D008727Q000494 http://id.nlm.nih.gov/mesh/D000069579Q000494 http://id.nlm.nih.gov/mesh/D000818 http://id.nlm.nih.gov/mesh/D007249Q000517 http://id.nlm.nih.gov/mesh/D018501Q000494 http://id.nlm.nih.gov/mesh/D001842Q000473 http://id.nlm.nih.gov/mesh/D001169Q000473 http://id.nlm.nih.gov/mesh/D013154Q000473 http://id.nlm.nih.gov/mesh/D008099Q000473
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_db534dfb811794dcf8169959477d8ea5 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID6965 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID6969 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID6966 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID126941 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_4fb3b68e84149f91bcfd0102f95d3731 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8173 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID11449 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7548 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_55951d083b23671206bcbc59ba93ee8e http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_714b3f52d8149c3277181d9513b93112 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9109

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID53790123 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID53787082

Total number of triples: 68.